The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world
Tóm tắt
Since the first World Health Organization notification on 31 December 2019, coronavirus disease 2019 (COVID‐19), the respiratory disease caused by the coronavirus severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2), has been responsible for over four million confirmed infections and almost 300 000 deaths worldwide. The pandemic has led to over half of the world's population living under lockdown conditions. To allow normal life to resume, public health interventions will be needed to prevent further waves of infections as lockdown measures are lifted. As one of the most effective countermeasures against infectious diseases, an efficacious vaccine is considered crucial to containing the COVID‐19 pandemic. Following the publication of the genome sequence of SARS‐CoV‐2, vaccine development has accelerated at an unprecedented pace across the world. Here we review the different platforms employed to develop vaccines, the standard timelines of development and how they can be condensed in a pandemic situation. We focus on vaccine development in the UK and vaccines that have entered clinical trials around the world.
Từ khóa
Tài liệu tham khảo
worldometers.info.Coronavirus death rate 2020. URLhttps://www.worldometers.info/coronavirus/[accessed on 14 May 2020].
worldometers.info.Countries where Coronavirus has spread 2020. URLhttps://www.worldometers.info.coronavirus/countries‐where‐coronavirus‐has‐spread/[accessed on 15 May 2020].
WHO.int.WHO Director‐General's opening remarks at the media briefing on COVID‐19 11 March 2020 2020. URLhttps://www.who.int/dg/speeches/detail/who‐director‐general‐s‐opening‐remarks‐at‐the‐media‐briefing‐on‐covid‐19‐‐‐11‐march‐2020[accessed on 21 April 2020].
PublicHeath.org.How Vaccines Work 2020. URLhttps://www.publichealth.org/public‐awareness/understanding‐vaccines/vaccines‐work/[accessed on 16 April 2020].
Codagenix.com.Platform Overview 2020. URLhttps://codagenix.com/technology/platform‐overview/[accessed on 16 April 2020].
Doremalen N, 2020, A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques, Sci Adv
WHO.int.Four countries in the African region license vaccine in milestone for ebola prevention.https://www.who.int/news‐room/detail/14‐02‐2020‐four‐countries‐in‐the‐african‐region‐license‐vaccine‐in‐milestone‐for‐ebola‐prevention[accessed on 10 May 2020].
WilsonJ.In pictures: the Imperial lab developing a COVID‐19 vaccine 2020. URLhttps://www.imperial.ac.uk/news/196313/in‐pictures‐imperial‐developing‐covid19‐vaccine/[accessed on 16 April 2020].
bristol.ac.uk.New vaccine platform used to develop COVID‐19 candidates 2020. URLhttp://www.bristol.ac.uk.news/2020/april/covid‐19‐vaccine‐platform.html[accessed on 20 May 2020].
DioSynVax.DioSynVax COVID Response 2020. URLhttps://www.worldometers.info/coronavirus/[accessed on 15 May 2020].
covid19vaccinetrial.co.uk.COVID‐19 vaccine trial 2020. URLhttps://covid19vaccinetrial.co.uk
Doremalen N, 2019, A single‐dose ChAdOx1‐vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters, PLoS Negl Trop Dis, 13, e0007462, 10.1371/journal.pntd.0007462
clinicaltrials.gov.A clinical trial to determine the safety and immunogenicity of healthy candidate MERS‐CoV vaccine (MERS002) 2019. URLhttps://clinicaltrials.gov.ct2/show/NCT04170829[accessed on 5 June 2020].
clinicaltrials.gov.Safety and immunogenicity of a candidate MERS‐CoV vaccine (MERS001) 2019.https://clinicaltrials.gov.ct2/show/NCT03399578[accessed on 16 May 2020].
clinicaltrials.gov.Study of a Candidate COVID‐19 vaccine (COV001) 2020.https://clinicaltrials.gov/ct2/show/NCT04324606?cond=covid‐19+vaccine&draw=2&rank=1[accessed on 16 May 2020].
covid19vaccinetrial.co.uk.How long will it take to get the Oxford vaccine to deployment?2020. URLhttps://covid19vaccinetrial.co.uk/blog‐how‐long‐will‐it‐take‐get‐oxford‐vaccine‐deployment[accessed on 5 June 2020].
WHO.DRAFT landscape of COVID‐19 candidate vaccines 2020. URLhttps://www.who.int/blueprint/priority‐diseases/key‐action/novel‐coronavirus‐landscape‐ncov.pdf?ua=1[accessed on 5 May 2020].
BioNTech.BioNTech Pipeline 2019. URLhttps://biontech.de/science/pipeline[accessed on 5 June 2020].
Inovio.Inovio Pharmaceuticals selected by CEPI to develop vaccine against new coronavirus 2020.http://ir.inovio.com/news‐and‐media/news/press‐release‐details/2020/Inovio‐Selected‐by‐CEPI‐to‐Develop‐Vaccine‐Against‐New‐Coronavirus/default.aspx[accessed on 15 May 2020].
FergusonN LaydonD Nedjati GilaniG ImaiN AinslieK BaguelinMet al.Report 9: Impact of non‐pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand 2020.